Search clinical trials for: Muscle Invasive Bladder Cancer (MIBC)
Total 101984 results
-
Assiut UniversityNot yet recruitingMuscle-Invasive Bladder Carcinoma
-
Tianjin Medical University Second HospitalRecruiting
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Syndax PharmaceuticalsActive, not recruitingBladder CancerUnited States
-
Ottawa Hospital Research InstituteAstraZeneca; Hamilton Health Sciences Corporation; London Health Sciences Centre and other collaboratorsRecruitingBladder CancerCanada
-
Merck Sharp & Dohme LLCSeagen Inc.; Astellas Pharma Global Development, Inc.Active, not recruitingUrinary Bladder Cancer, Muscle-invasiveCanada, United States, Australia, Belgium, France, Hungary, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Thailand, Ukraine, Argentina, Colombia, Denmark, Germany, Ireland, Israel, Japan, Malaysia, Philippines, Sing... and more
-
Janssen Research & Development, LLCRecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorKorea, Republic of, United States, Germany, Spain, Netherlands
-
Masonic Cancer Center, University of MinnesotaBristol-Myers SquibbCompletedMuscle Invasive Bladder CancerUnited States
-
Samsung Medical CenterActive, not recruitingMuscle-Invasive Bladder Carcinoma | Radical Cystectomy | Multiparametric MRI | Vesical Imaging Report and Data SystemKorea, Republic of
-
Swiss Group for Clinical Cancer ResearchRecruitingBladder CancerSwitzerland
-
H. Lee Moffitt Cancer Center and Research InstituteCG Oncology, Inc.; Richard M. Shulze Family FoundationActive, not recruitingBladder Cancer | Muscle-Invasive Bladder CarcinomaUnited States
-
RenJi HospitalRecruitingRadiotherapy | Muscle Invasive Bladder Cancer | PD-1 | HER2 Expression | Antibody-drug ConjugatesChina
-
Pusan National University Yangsan HospitalRecruitingUrothelial Carcinoma | Neoadjuvant Chemotherapy | Muscle Invasive Bladder CancerKorea, Republic of
-
UNICANCERRecruitingPatients With High-risk MIBCFrance
-
Chinese PLA General HospitalBeijing GeneX Health Technology Co., LtdRecruitingMuscle-Invasive Bladder CarcinomaChina
-
Zhujiang HospitalRecruitingBladder Cancer | Muscle-Invasive Bladder CarcinomaChina
-
Leslie BallasNot yet recruitingMuscle-Invasive Bladder Carcinoma | TumorUnited States
-
AstraZenecaActive, not recruitingMuscle Invasive Bladder CancerUnited States, Belgium, France, Germany, Italy, Spain, United Kingdom, Canada, Poland, Taiwan, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, Japan, Philippines, Israel, Chile, Australia, Netherlands, Russian Federation
-
Aura BiosciencesRecruitingMuscle-Invasive Bladder Carcinoma | Non-muscle-invasive Bladder CancerUnited States
-
Hellenic GenitoUrinary Cancer GroupRecruiting
-
Kyoto University HospitalMerck Sharp & Dohme LLC; Astellas Pharma Inc; University of Tsukuba; Kobe City... and other collaboratorsRecruiting
-
Jørgen Bjerggaard JensenOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Herlev Hospital and other collaboratorsRecruitingBladder Cancer | Bladder Cancer, MetastaticDenmark
-
Mansoura UniversityActive, not recruitingBladder Cancer | Diagnoses Disease | Bladder Disease | Bladder Urothelial Carcinoma | Bladder Neoplasm | MRI Contrast Media Adverse Reaction | Bladder Cancer StageEgypt
-
AstraZenecaActive, not recruitingMuscle Invasive Bladder CancerSpain, United States, Canada, France, United Kingdom
-
University of Texas Southwestern Medical CenterNot yet recruitingMuscle Invasive Bladder Cancer
-
M.D. Anderson Cancer CenterBoehringer IngelheimTerminatedBreast CancerUnited States
-
zr Pharma & GmbHFoundation MedicineTerminatedBladder Cancer | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Muscle Invasive Bladder Cancer | Ureter Carcinoma | Renal Pelvis Carcinoma | Urinary Bladder Carcinoma | Urethra CarcinomaUnited States, Spain, France, Italy, Germany, United Kingdom
-
UNICANCERRoche Pharma AGRecruiting
-
University Hospital, GhentKom Op Tegen KankerRecruitingMuscle-Invasive Bladder CarcinomaBelgium
-
King's College LondonRecruitingSurgery | Patient Satisfaction | Patient Preference | Muscle Invasive Bladder Cancer | Sexual WellbeingUnited Kingdom
-
Janssen Research & Development, LLCRecruitingUrinary Bladder NeoplasmsTaiwan, Korea, Republic of, Austria, Germany, China, United States, Greece, Italy, Argentina, Belgium, Brazil, Russian Federation, Spain, Canada, Czechia, France, Mexico, Japan, Poland, Portugal, Australia, Hungary, India, Ukraine, Turkey
-
Merck Sharp & Dohme LLCRecruitingUrinary Bladder NeoplasmsUnited States, Australia, Czechia, Estonia, France, Guatemala, Hungary, Israel, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Poland, Portugal, Puerto Rico, Romania, Spain, Taiwan, Turkey, Ukraine, United Kingdom, Denmark, ... and more
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBladder CancerUnited States
-
Baylor College of MedicinePfizerTerminatedBladder Cancer | Invasive Bladder Cancer | Metastatic Bladder CancerUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingBladder CancerCanada, United States, Australia, Belgium, Denmark, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Sweden, Thailand, Turkey, Ukraine, United Kingdom
-
Merck Sharp & Dohme LLCAstellas Pharma Inc; Seagen Inc.Active, not recruitingBladder CancerHungary, United States, China, Argentina, Australia, Bulgaria, Canada, Colombia, Croatia, Czechia, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Malaysia, Philippines, Poland, Portugal, Romania, Russian Federation, Singapo... and more
-
NanOlogy, LLCUS Biotest, Inc.CompletedUrologic Neoplasms | Urogenital Neoplasms | Urinary Bladder Cancer | Bladder Cancer | Urothelial Carcinoma | Urologic Cancer | Urinary Bladder Neoplasm | Cancer of the Bladder | Malignant Tumor of the Urinary BladderUnited States
-
Istituto Nazionale di Ricovero e Cura per AnzianiCompleted
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.Active, not recruitingUrologic Neoplasms | Urinary Bladder Neoplasms | Carcinoma, Transitional Cell | Ureteral Neoplasms | Urothelial Cancer | Urethral Neoplasms | Renal Pelvis NeoplasmsUnited States, Italy, Spain, Canada, France, Puerto Rico
-
Dana-Farber Cancer InstitutePfizerRecruitingBladder Cancer | Muscle Invasive Bladder CancerUnited States
-
Fudan UniversityRecruitingBladder CancerChina
-
Fox Chase Cancer CenterJanssen PharmaceuticalsNot yet recruitingUrothelial Carcinoma | Non-Muscle Invasive Bladder Urothelial Carcinoma | Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
University of Texas Southwestern Medical CenterAstellas Pharma IncNot yet recruiting
-
National Cancer Center, KoreaRecruitingBladder CancerKorea, Republic of
-
RemeGen Co., Ltd.Not yet recruitingHigh-risk Non-muscle Invasive Bladder CancerChina
-
Dokuz Eylul UniversityNot yet recruitingBladder Cancer | Gemcitabine | BCG | Docetaxel | Intravesical InstillationTurkey
-
Yonsei UniversityRecruitingMuscle-invasive Bladder CancerKorea, Republic of
-
The First Affiliated Hospital with Nanjing Medical...RecruitingArtificial Intelligence | Muscle-invasive Bladder CancerChina
-
Ractigen Therapeutics.RecruitingNon-Muscle-Invasive Bladder Cancer (NMIBC)Australia
-
Valenta Pharm JSCRecruiting